Information Center

Cooperative clients

Release time:

2023-04-19 23:47

User reviews and feedback:

Nanjing Baidier Biopharmaceutical Co., Ltd. transferred the raw material and capsule development technology of lenalidomide to our company. This technology is mature and stable, with reliable quality. After acquiring the raw material development technology and capsule development technology of this product, our company completed further industrial scale-up production based on this foundation, successfully completed multiple batches of validation production, and passed the bioequivalence study.

Previous Page

Next Page

Previous Page

Next Page


Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com

©2024 Zhejiang Kanova biopharmaceutical Co., LTD

Power by:300.cn  Beijing

Business License